Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Differential regulation of SOCS genes in normal and transformed erythroid cells

Abstract

The SOCS family of genes are negative regulators of cytokine signalling with SOCS-1 displaying tumor suppressor activity. SOCS-1, CIS and SOCS-3 have been implicated in the regulation of red blood cell production. In this study, a detailed examination was conducted on the expression patterns of these three SOCS family members in normal erythroid progenitors and a panel of erythroleukemic cell lines. Unexpectedly, differences in SOCS gene expression were observed during maturation of normal red cell progenitors, viz changes to CIS were inversely related to the alterations of SOCS-1 and SOCS-3. Similarly, these SOCS genes were differentially expressed in transformed erythoid cells – erythroleukemic cells immortalized at an immature stage of differentiation expressed SOCS-1 and SOCS-3 mRNA constitutively, whereas in more mature cell lines SOCS-1 and CIS were induced only after exposure to erythropoietin (Epo). Significantly, when ectopic expression of the tyrosine kinase Lyn was used to promote differentiation of immature cell lines, constitutive expression of SOCS-1 and SOCS-3 was completely suppressed. Modulation of intracellular signalling via mutated Epo receptors in mature erythroleukemic lines also highlighted different responses by the three SOCS family members. Close scrutiny of SOCS-1 revealed that, despite large increases in mRNA levels, the activity of the promoter did not alter after erythropoietin stimulation; in addition, erythroid cells from SOCS-1−/− mice displayed increased sensitivity to Epo. These observations indicate complex, stage-specific regulation of SOCS genes during normal erythroid maturation and in erythroleukemic cells.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Alexander WS, Starr R, Fenner JE, Scott CL, Handman E, Sprigg NS, Corbin JE, Cornish AL, Darwiche R, Owczarek CM, Kay TWH, Nicola NA, Hertzog PJ, Metcalf D and Hilton DJ . (1999). Cell, 98, 597–608.

  • Andrews NC, Erdjument-Bomage H, Davidson MB, Tempst P and Orkin SH . (1993). Nature, 362, 722–728.

  • Bieker JJ and Southwood CM . (1995). Mol. Cell. Biol., 15, 852–860.

  • Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C and Darnell Jr JE . (1999). Cell, 98, 295–303.

  • Brysha M, Zhang J, Bertolino P, Corbin J, Alexander W, Nicola N, Hilton D and Starr R . (2001). J. Biol. Chem., 276, 22086–22089.

  • Busfield SJ and Klinken SP . (1992). Blood, 80, 412–419.

  • Cacalano NA, Sanden D and Johnston JA . (2001). Nat. Cell Biol., 3, 460–465.

  • Chomczynski P and Sacchi N . (1987). Anal. Biochem., 162, 156–169.

  • Cohney SJ, Sanden D, Cacalano NA, Yoshimura A, Mui A, Migone TS and Johnston JA . (1999). Mol. Cel.l Biol., 19, 4980–4988.

  • Constantinescu SN, Ghaffari S and Lodish HF . (1999). Trends Endocrin. Metab., 10, 18–23.

  • Cooper MC, Levy J, Cantor LN, Marks PA and Rifkind RA . (1974). Proc. Natl. Acad. Sci. USA, 71, 1677–1680

  • Cory S, Maekawa T, McNeall J and Metcalf D . (1991). Cell Growth Differ., 2, 165–172.

  • Cull V, Tilbrook PA, Adenan AS, Chappell D, Ingley E, Sarna MK, Palmer TN, Watowich SS and Klinken SP . (2000). Oncogene, 19, 953–960.

  • D’Andrea AD, Yoshimura A, Yousoufian H, Zon LI, Koo J-W and Lodish HF . (1991). Mol. Cell. Biol., 11, 1980–1987.

  • De Jong MO, Wagemaker G and Wognum AW . (1995). Blood, 86, 4076–4085.

  • De Sepulveda P, Okkenhaug K, La Rose J, Hawley RG, Dubreuil P and Rottapel R . (1999). EMBO J., 18, 904–915.

  • Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawa H, Miyazaki T, Leonor N, Taniguchi T, Fujita T, Kanakura Y, Komiya S and Yoshimura A . (1997). Nature, 387, 921–924.

  • Gregorieff A, Pyronnet S, Sonenberg N and Veillette A . (2000). J. Biol. Chem., 275, 21596–21604.

  • Hawley RG, Lieu FHL, Fong AZC and Hawley TS . (1994). Gene Theraphy, 1, 136–138.

  • Hilton DJ, Richardson RT, Alexander WS, Viney EM, Willson TA, Sprigg NS, Starr R, Nicholson SE, Metcalf D and Nicola NA . (1998). Proc. Natl. Acad. Sci. USA, 95, 114–119.

  • Hodges V, Winter P and Lappin T . (1999). Br. J. Haematol., 106, 325–334.

  • Iacopetta BJ, Morgan EH and Yeoh GC . (1982). Biochim. Biophys. Acta, 687, 204–210.

  • Ihle JN . (1995). Nature, 377, 591–594.

  • Ikuta K, Kina T, McNeill I, Uchida N, Peault B, Chein Y and Weissman I . (1990). Cell, 62, 863–874.

  • Kamura T, Sato S, Haque D, Liu L, Kaelin Jr WG, Conaway RC and Conaway JW . (1998). Gene Dev., 12, 3872–3881.

  • Klingmuller U . (1997). Eur. J. Biochem., 249, 637–647.

  • Klingmuller U, Lorenz U, Cantley LC, Neel BG and Lodish HF . (1995). Cell, 80, 729–738.

  • Klinken SP and Nicola NA . (1990). Leukemia, 4, 24–28.

  • Klinken SP, Nicola NA and Johnson GR . (1988). Proc. Natl. Acad. Sci. USA, 85, 8506–8510.

  • Koury MJ and Bondurant MC . (1992). Eur. J. Biochem., 210, 649–663.

  • Lacronique V, Boureux A, Della Valle V, Poirel H, Tran Quang C, Mauchauffe M, Berthou C, Lessard M, Berger R, Ghysdael J and Bernard O . (1997). Science, 278, 1309–1312.

  • Landschulz KT, Noyes AN, Rogers O and Boyer SJ . (1989). Blood, 73, 1476–1486.

  • Marine J-C, McKay C, Wang D, Topham DJ, Parganas E, Nakajima H, Pendeville H, Yasukawa H, Sasaki A, Yoshimura A and Ihle JN . (1999). Cell, 98, 617–627.

  • Marshall CJ . (1988). J. Cell. Sci. Suppl., 10, 157–169.

  • Matsumoto A, Masuhara M, Mitsui K, Yokouchi M, Ohtsubo M, Misawa H, Miyajima A and Yoshimura A . (1997). Blood, 89, 3148–3154.

  • Metcalf D, Alexander WS, Elefanty AG, Nicola NA, Hilton DJ, Starr R, Mifsud S and Di Rago L . (1999). Leukemia, 13, 926–934.

  • Metz T, Harris AW and Adams JM . (1995). Cell, 82, 29–36.

  • Miller IJ and Bieker JJ . (1993). Mol. Cell. Biol., 13, 2776–2786.

  • Miura O, Nakamura N, Quelle FW, Witthuhn BA, Ihle JN and Aoki N . (1994). Blood, 84, 1501–1507

  • Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, Nishimoto N, Kajita T, Taga T, Yoshizaki K, Akira S and Kishimoto T . (1997). Nature, 387, 924–929.

  • Ogawa M, Matsuzaki Y, Nishikawa S, Hayashi S, Kunisada T, Sudo T, Kina T, Nakauchi H and Nishikawa S . (1991). J. Exp. Med., 174, 63–71.

  • Ohya K, Kajigaya S, Yamashita Y, Miyazato A, Hatake K, Miura Y, Ikeda U, Shimada K, Ozawa K and Mano H . (1997). J. Biol. Chem., 272, 27178–27182.

  • Piechaczyk M, Blanchard J, Martin L, Dani C, Panabries F, El Sabrouty S and Jeanteur P . (1984). Nucleic Acids Res., 12, 6951–6963.

  • Pircher TJ, Geiger JN, Zhang DY, Miller CP, Gaines P and Wojchowski DM . (2001). J. Biol. Chem., 276, 8995–9002.

  • Rayner JR and Gonda TJ . (1994). Mol. Cell. Biol., 14, 880–887.

  • Roberts AW, Robb L, Rakar S, Hartley L, Cluse L, Nicola NA, Metcalf D, Hilton DJ and Alexander WS . (2001). Proc. Natl. Acad. Sci., 98, 9324–9329.

  • Rottapel R, Ilangumaran S, Neale C, La Rose J, Ho JM, Nguyen MH, Barber D, Dubreuil P and de Sepulveda P . (2002). Oncogene, 21, 4351–4362.

  • Saito H, Morita Y, Fujimoto M, Narazaki M, Naka T and Kishimoto T . (2000). J. Immunol., 164, 5833–5843.

  • Sasaki A, Yasukawa H, Shouda T, Kitamura T, Dikic I and Yoshimura A . (2000). J. Biol. Chem., 275, 29338–29347.

  • Schluter G, Boinska D and Nieman-Seyde SC . (2000). Biochem. Biophys. Res. Commun., 268, 255–261.

  • Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA and Hilton DJ . (1997). Nature, 387, 917–921.

  • Tilbrook PA, Bittorf T, Busfield SJ, Chappell D and Klinken SP . (1996a). J. Biol. Chem., 271, 3453–3459.

  • Tilbrook PA, Bittorf T, Callus B, Busfield SJ, Ingley E and Klinken SP . (1996b). Cell Growth Differ., 7, 511–520.

  • Tilbrook PA, Colley SM, McCarthy DJ, Marais R and Klinken SP . (2001a). Arch. Biochem. Biophys., 396, 128–132

  • Tilbrook PA, Ingley E, Williams JH, Hibbs ML and Klinken SP . (1997). EMBO J., 16, 1610–1619.

  • Tilbrook PA and Klinken SP . (1999). Growth Factors, 17, 25–35.

  • Tilbrook PA, Palmer GA, Bittorf T, McCarthy DJ, Wright MJ, Sarna MK, Linnekin D, Cull V, Williams JH, Ingley E, Schneider-Mergener J, Krystal G and Klinken SP . (2001b). Cancer Res., 61, 2453–2458.

  • Trowbridge IS, Lesley J and Schulte R . (1982). J. Cell Physiol., 112, 403–410.

  • Uoshima N, Ozawa M, Kimura S, Tanaka K, Wada K, Kobayashi Y and Kondo M . (1995). Brit. J. Haematol., 91, 30–36.

  • Vannucchi AM, Paoletti F, Linari S, Cellai C, Caporale R, Ferrini PR, Sanchez M, Migliaccio G and Migliaccio AR . (2000). Blood, 95, 2559–2568.

  • Verdier F, Chretien S, Muller O, Varlet P, Yoshimura A, Gisselbrecht S, Lacombe C and Mayeux P . (1998a). J. Biol. Chem., 273, 28185–28190.

  • Verdier F, Rabionet R, Gouilleux F, Beisenherzhuss C, Varlet P, Muller O, Mayeux P, Lacombe C, Gisselbrecht S and Chretien S . (1998b). Mol. Cell. Biol., 18, 5852–5860.

  • Waldmann V and Rabes HM . (1996). Pathol. Res. Prac., 192, 883–891.

  • Yoshikawa H, Matsubara K, Qian GS, Jackson P, Groopman JD, Manning JE, Harris CC and Herman JG . (2001). Nat. Genet., 28, 29–35.

  • Yoshimura A, Ohkubo T, Kiguchi T, Jenkins NA, Gilbert DJ, Copeland NG, Hara T and Miyajima A . (1995). EMBO J., 14, 2816–2826.

  • Zhang JG, Farley A, Nicholson SE, Willson TA, Zugaro LM, Simpson RJ, Moritz RL, Cary D, Richardson R, Hausmann G, Kile BJ, Kent SBH, Alexander WS, Metcalf D, Hilton DJ, Nicola NA and Baca M . (1999). Proc. Natl. Acad. Sci. USA, 96, 2071–2076.

Download references

Acknowledgements

We acknowledge the expert technical assistance from Shane Meakins, Research Centre, Royal Perth Hospital. Recombinant human Epo (Eprex) was a generous gift from Dr J Adams and Dr J Patava (Janssen-Cilag, Australia). This work was supported by grants from NHMRC (#99-0596 and the Block Grant to the Walter and Eliza Hall Institute), the Cancer Foundation of Western Australia, the Medical Research Foundation of Royal Perth Hospital, The Neurotrauma Research Program of Western Australia, the National Institutes of Health, Bethesda, Maryland (Grant CA-22556), National Cancer Institute and The National Institutes of Health, Bethesda, Maryland (Grant CA-77447). SJB is an NHMRC RD Wright Postdoctoral Fellow. RS was supported by a Postdoctoral Fellowship from the Australian Research Council.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to S Peter Klinken.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sarna, M., Ingley, E., Busfield, S. et al. Differential regulation of SOCS genes in normal and transformed erythroid cells. Oncogene 22, 3221–3230 (2003). https://doi.org/10.1038/sj.onc.1206381

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1206381

This article is cited by

Search

Quick links